carbamates has been researched along with Critical Illness in 2 studies
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 days) and cumulative dosage (316 mg vs." | 3.30 | Hemoperfusion for Clinically Suspected Organophosphate and Carbamate Poisoning in Critically Ill Patients: A Randomized Trial. ( George, JA; Khoza, S; Madi, S; Mashamba, L; Mathivha, LR; Omar, S; Sooka, PN; Van Rooyen, MC, 2023) |
| "The aim of this review was to evaluate current literature for dosing recommendations for the use of antiepileptic medications in patients receiving renal replacement therapy (RRT)." | 2.53 | Antiepileptic dosing for critically ill adult patients receiving renal replacement therapy. ( Bastin, ML; Cook, AM; Oyler, DR; Smetana, KS, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Omar, S | 2 |
| Sooka, PN | 2 |
| Khoza, S | 2 |
| Van Rooyen, MC | 2 |
| Mashamba, L | 2 |
| Madi, S | 2 |
| Mathivha, LR | 2 |
| George, JA | 2 |
| Smetana, KS | 1 |
| Cook, AM | 1 |
| Bastin, ML | 1 |
| Oyler, DR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Study of Pharmacokinetics of Levetiracetam in Patients Undergoing Intermittent Hemodialysis[NCT04511676] | 12 participants (Actual) | Observational | 2018-11-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for carbamates and Critical Illness
| Article | Year |
|---|---|
Antiepileptic dosing for critically ill adult patients receiving renal replacement therapy.
Topics: Acetamides; Acute Kidney Injury; Amines; Anticonvulsants; Carbamates; Critical Illness; Cyclohexanec | 2016 |
1 trial available for carbamates and Critical Illness
| Article | Year |
|---|---|
Hemoperfusion for Clinically Suspected Organophosphate and Carbamate Poisoning in Critically Ill Patients: A Randomized Trial.
Topics: Adult; Carbamates; Critical Illness; Hemoperfusion; Humans; Intensive Care Units; Organophosphates; | 2023 |
Hemoperfusion for Clinically Suspected Organophosphate and Carbamate Poisoning in Critically Ill Patients: A Randomized Trial.
Topics: Adult; Carbamates; Critical Illness; Hemoperfusion; Humans; Intensive Care Units; Organophosphates; | 2023 |
Hemoperfusion for Clinically Suspected Organophosphate and Carbamate Poisoning in Critically Ill Patients: A Randomized Trial.
Topics: Adult; Carbamates; Critical Illness; Hemoperfusion; Humans; Intensive Care Units; Organophosphates; | 2023 |
Hemoperfusion for Clinically Suspected Organophosphate and Carbamate Poisoning in Critically Ill Patients: A Randomized Trial.
Topics: Adult; Carbamates; Critical Illness; Hemoperfusion; Humans; Intensive Care Units; Organophosphates; | 2023 |